Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Lesalpes29

T.ONC

RE:RE:Pharma faces looming patent cliff - seller's market in bio

I'm with you Fox... do I have enough of this reposting in repetention...

April 1, 2023

T.OSK

RE:So do i own part of vior?

Exactly.

March 31, 2023

V.TLT

.25-.26 floor!

Time to get back up. BTD with positive comments or more positive results...

March 31, 2023

T.ONC

RE:RE:RE:RE:RE:RE:Time for shareholder activism?

We don't need an actvist... just need deals before summer! Week after...

March 30, 2023

T.ONC

RE:RE:RE:RE:RE:Time for shareholder activism?

Oops King!

March 30, 2023

T.ONC

RE:RE:RE:RE:Time for shareholder activism?

Noteable = paranoia... Who are you Notebale? The Kink of this BB... look at...

March 30, 2023

V.TLT

RE:RE:RE:RE:RE:Has FDA moved the goalposts?

Good post again Steven. It's easy to turn negatively every move or...

March 30, 2023

T.ONC

Next week presentation at Cantor.

Hope we will have something like a positive NR just before. Just to push a...

March 30, 2023

T.ONC

RE:RE:Cantor

2023 is the turning point year. Next two months will be ower time. My...

March 29, 2023

T.ONC

RE:Cantor

Part of the strategy to create a big wave of buying. GL

March 28, 2023

V.TLT

RE:What is going on?

Be in the dark like this is frustrating. Do we have to wait until next...

March 28, 2023

T.ONC

RE:RE:RE:RE:keep the enthusiasm in check

Agree with both of you. Now what is the real value of a drug that could be...

March 28, 2023

T.OSK

RE:Heavy duty accumulation

What people think here? Volume and price spike, why? 

March 27, 2023

T.ONC

RE:keep the enthusiasm in check

Keep posting here to have a balance point of vue. We have a product not good...

March 27, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA guides on how AA can be converted to full approval.

No phase 3 yet, no guarantee that a phase 3 would be successfull, market cap...

March 26, 2023

T.ONC

RE:RE:Great contrary indicator/ time to buy

Let's go Matt pwer market cap is less than 80M usd! Why?

March 24, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:SP

Good recap. I want you to join the BOD to help them during the actual...

March 24, 2023

T.ONC

RE:RE:Great contrary indicator/ time to buy

It's probably not the lowest price for the next 3 months. Imagine 3...

March 23, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Six month cysto today

Really hope we are close to get a partner with the know/how and money! First...

March 23, 2023

T.ONC

RE:The Difference in ONC/Y Before and After 2016 (and more)

Good post about the story and where we stand. Not in favor to accept a low...

March 22, 2023

Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next

Featured Company

Royalties Inc.

Royalties Inc. C.RI

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ... view more »